- Home
- EVAX vs ONFO Comparison
EVAX vs ONFO Comparison
Compare EVAX & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVAX | ONFO |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 3.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVAX | ONFO |
|---|---|---|
| Price | $3.52 | $0.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.67 | N/A |
| AVG Volume (30 Days) | 31.7K | ★ 91.0K |
| Earning Date | 03-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $0.46 |
| 52 Week High | $12.15 | $1.95 |
Technical Indicators
Market Signals| Indicator | EVAX | ONFO |
|---|---|---|
| Relative Strength Index (RSI) | 46.95 | 58.46 |
| Support Level | $2.45 | $0.60 |
| Resistance Level | $3.62 | $0.82 |
| Average True Range (ATR) | 0.41 | 0.08 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 30.00 | 78.64 |
Price Performance
Historical ComparisonAbout EVAX Evaxion Biotech
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.